BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26287968)

  • 1. Xeno-Klotho Inhibits Parathyroid Hormone Signaling.
    Takenaka T; Inoue T; Miyazaki T; Hayashi M; Suzuki H
    J Bone Miner Res; 2016 Feb; 31(2):455-62. PubMed ID: 26287968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.
    Sneddon WB; Ruiz GW; Gallo LI; Xiao K; Zhang Q; Rbaibi Y; Weisz OA; Apodaca GL; Friedman PA
    J Biol Chem; 2016 Sep; 291(36):18632-42. PubMed ID: 27432882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes.
    Bacchetta J; Sea JL; Chun RF; Lisse TS; Wesseling-Perry K; Gales B; Adams JS; Salusky IB; Hewison M
    J Bone Miner Res; 2013 Jan; 28(1):46-55. PubMed ID: 22886720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
    J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4.
    Gattineni J; Twombley K; Goetz R; Mohammadi M; Baum M
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F371-7. PubMed ID: 21561999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Classical Effects of FGF23: Molecular and Clinical Features.
    Martínez-Heredia L; Canelo-Moreno JM; García-Fontana B; Muñoz-Torres M
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis.
    Nabeshima Y
    Cell Mol Life Sci; 2008 Oct; 65(20):3218-30. PubMed ID: 18726073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis.
    Nabeshima Y
    Proc Jpn Acad Ser B Phys Biol Sci; 2009; 85(3):125-41. PubMed ID: 19282648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic causes of hypophosphatemia.
    Puente N; Solis P; Riancho JA
    Minerva Med; 2024 Jun; 115(3):320-336. PubMed ID: 38727708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis.
    Medici D; Razzaque MS; Deluca S; Rector TL; Hou B; Kang K; Goetz R; Mohammadi M; Kuro-O M; Olsen BR; Lanske B
    J Cell Biol; 2008 Aug; 182(3):459-65. PubMed ID: 18678710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an α-Klotho Recognizing High-Affinity Peptide Probe from In-Solution Enrichment.
    Zhang P; Ye X; Wang JCK; Smith CL; Sousa S; Loas A; Eaton DL; Preciado López M; Pentelute BL
    JACS Au; 2024 Apr; 4(4):1334-1344. PubMed ID: 38665650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease.
    Ding HY; Ma HX
    J Geriatr Cardiol; 2015 Jul; 12(4):439-47. PubMed ID: 26347327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho, stem cells, and aging.
    Bian A; Neyra JA; Zhan M; Hu MC
    Clin Interv Aging; 2015; 10():1233-43. PubMed ID: 26346243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of renal phosphate handling: inter-organ communication in health and disease.
    Tatsumi S; Miyagawa A; Kaneko I; Shiozaki Y; Segawa H; Miyamoto K
    J Bone Miner Metab; 2016 Jan; 34(1):1-10. PubMed ID: 26296817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate as a cardiovascular risk factor: effects on vascular and endothelial function.
    Stevens KK; Patel RK; Mark PB; Delles C; Jardine AG
    Lancet; 2015 Feb; 385 Suppl 1():S10. PubMed ID: 26312829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
    Moysés RM; Schiavi SC
    Semin Dial; 2015; 28(6):578-86. PubMed ID: 26288182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.
    Fan Y; Bi R; Densmore MJ; Sato T; Kobayashi T; Yuan Q; Zhou X; Erben RG; Lanske B
    FASEB J; 2016 Jan; 30(1):428-40. PubMed ID: 26428657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice.
    Leibrock CB; Alesutan I; Voelkl J; Michael D; Castor T; Kohlhofer U; Quintanilla-Martinez L; Kübler L; Mannheim JG; Pichler BJ; Rosenblatt KP; Kuro-o M; Lang F
    J Mol Med (Berl); 2016 Jan; 94(1):95-106. PubMed ID: 26307633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.